ImageneBio (IMA) Earnings Analysis

ImageneBio (IMA) next reports earnings on 2026-07-23, consensus EPS -0.97667 USD. Last quarter (2026-05-07) it missed with EPS -0.95 USD vs -0.7 USD est (-35.7%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -1.29.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does IMA next report earnings?

Next earnings date2026-07-23
Consensus EPS estimate-0.97667 USD
Revenue estimaten/a

IMA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-0.95 USD-0.7 USD-35.7%Miss
2026-03-10-0.62 USD-1.45 USD+57.2%Beat
2025-11-12-2.91 USD-1.47 USD-98%Miss
2025-07-24-0.06 USD-0.14 USD+57.1%Beat
2025-05-08-0.18 USD-0.21 USD+14.3%Beat
2025-03-06-0.18 USD-0.19 USD+5.3%Beat
2024-11-07-0.19 USD-0.27 USD+29.6%Beat

Beat rate: 5/7 (71%) over reported quarters with consensus data.

IMA valuation and analyst view

Trailing P/E-1.29
Trailing EPS-4.02033 USD
Price / book0.54
Dividend yield0.00%
Market cap0.07B
Analyst consensusBuy (4 buy / 0 hold / 1 sell)

Related research pages

Frequently asked questions

When is ImageneBio (IMA)'s next earnings date?

ImageneBio is next scheduled to report on 2026-07-23, with a consensus EPS estimate of -0.97667 USD.

Did IMA beat earnings last quarter?

In its 2026-05-07 report, IMA posted EPS of -0.95 USD versus a -0.7 USD estimate — a miss of 35.7%.

What is IMA's earnings track record?

Over the last 7 reported quarters with consensus data, IMA beat estimates 5 times (71%).

What is IMA's current P/E ratio and EPS?

IMA trades at a trailing P/E of -1.29 on trailing EPS of -4.020330260591398 USD.

What do analysts rate IMA?

Analyst consensus is "Buy" across 5 ratings (0 strong buy, 4 buy, 0 hold, 1 sell, 0 strong sell).